ATE294167T1 - Chemische verbindungen - Google Patents

Chemische verbindungen

Info

Publication number
ATE294167T1
ATE294167T1 AT01994312T AT01994312T ATE294167T1 AT E294167 T1 ATE294167 T1 AT E294167T1 AT 01994312 T AT01994312 T AT 01994312T AT 01994312 T AT01994312 T AT 01994312T AT E294167 T1 ATE294167 T1 AT E294167T1
Authority
AT
Austria
Prior art keywords
chemical compounds
formula
compounds
present
beta
Prior art date
Application number
AT01994312T
Other languages
English (en)
Inventor
David N Deaton
Barry George Shearer
David Edward Uehling
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE294167T1 publication Critical patent/ATE294167T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • External Artificial Organs (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01994312T 2001-01-31 2001-12-17 Chemische verbindungen ATE294167T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0102408.2A GB0102408D0 (en) 2001-01-31 2001-01-31 Chemical compounds
PCT/US2001/049299 WO2002060885A1 (en) 2001-01-31 2001-12-17 Chemical compounds

Publications (1)

Publication Number Publication Date
ATE294167T1 true ATE294167T1 (de) 2005-05-15

Family

ID=9907834

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01994312T ATE294167T1 (de) 2001-01-31 2001-12-17 Chemische verbindungen

Country Status (23)

Country Link
EP (1) EP1366033B1 (de)
JP (1) JP2004521895A (de)
KR (1) KR20030070923A (de)
CN (1) CN1487928A (de)
AT (1) ATE294167T1 (de)
AU (1) AU2002246720B2 (de)
BR (1) BR0116854A (de)
CA (1) CA2434853A1 (de)
CZ (1) CZ20032085A3 (de)
DE (1) DE60110468T2 (de)
DK (1) DK1366033T3 (de)
ES (1) ES2240557T3 (de)
GB (1) GB0102408D0 (de)
HK (1) HK1060883A1 (de)
HU (1) HUP0303026A3 (de)
IL (2) IL156639A0 (de)
MX (1) MXPA03006847A (de)
NO (1) NO20033401L (de)
NZ (1) NZ526846A (de)
PL (1) PL363359A1 (de)
PT (1) PT1366033E (de)
WO (1) WO2002060885A1 (de)
ZA (1) ZA200305770B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0102407D0 (en) 2001-01-31 2001-03-14 Glaxo Group Ltd Process
US7709677B2 (en) 2001-01-31 2010-05-04 Glaxosmithkline Llc Process of preparing arylethanoldiamines
EP1424079A1 (de) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207964D0 (en) * 1992-04-10 1992-05-27 Ici Plc Chemical compounds
WO1995033724A1 (en) * 1994-06-09 1995-12-14 Glaxo Group Limited Phenethanolamine derivatives and their use as atypical beta-adrenoceptor agonists
GB9525177D0 (en) * 1995-12-08 1996-02-07 Glaxo Group Ltd Chemical compounds
GB9812709D0 (en) * 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
CZ20032085A3 (cs) 2003-12-17
DK1366033T3 (da) 2005-08-15
IL156639A (en) 2006-12-31
BR0116854A (pt) 2004-02-25
PL363359A1 (en) 2004-11-15
GB0102408D0 (en) 2001-03-14
HUP0303026A3 (en) 2007-06-28
PT1366033E (pt) 2005-08-31
NO20033401L (no) 2003-09-30
EP1366033B1 (de) 2005-04-27
MXPA03006847A (es) 2003-11-13
DE60110468T2 (de) 2006-02-23
WO2002060885A1 (en) 2002-08-08
CA2434853A1 (en) 2002-08-08
KR20030070923A (ko) 2003-09-02
AU2002246720B2 (en) 2004-07-22
ZA200305770B (en) 2004-10-25
DE60110468D1 (de) 2005-06-02
NO20033401D0 (no) 2003-07-30
EP1366033A1 (de) 2003-12-03
IL156639A0 (en) 2004-01-04
ES2240557T3 (es) 2005-10-16
JP2004521895A (ja) 2004-07-22
NZ526846A (en) 2004-10-29
CN1487928A (zh) 2004-04-07
HUP0303026A2 (hu) 2003-12-29
HK1060883A1 (en) 2004-08-27

Similar Documents

Publication Publication Date Title
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
EA200601552A1 (ru) Замещенные конденсированные гетероциклические с-гликозиды
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
DE60228103D1 (de) Chemische verbindungen
BG108225A (en) Thiohydantoins and use thereof for treating diabetes
BR0308243A (pt) Composto, formulação farmacêutica, e, métodos de tratar diabetes, doença de alzheimer, e de inibir gsk-3 em um mamìfero
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
GB0318447D0 (en) Therapeutic agents
SE0301700D0 (sv) Novel compounds
CY1110742T1 (el) Αναστολεις ινδαζολης, βενζισοξαζολης, και βενζισοθειαζολης
ATE449097T1 (de) Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer
EA200501771A1 (ru) Лиганды каннабиноидных рецепторов и их применения
UA86042C2 (en) Substituted indazole-o-glucosides
MXPA05012323A (es) Sulfonamidas ciclicas para la inhibicion de gama-secretasa.
ATE312096T1 (de) Neue verbindungen
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
SE0302304D0 (sv) Novel compounds
SE0300850D0 (sv) Chemical compounds
SE0200844D0 (sv) Chemical compounds
SE0200843D0 (sv) Chemical compounds
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
DE60110468D1 (de) Chemische verbindungen
NO20053562L (no) Nye aminobenzofenonforbindelser
DE60228295D1 (de) Chemische verbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1366033

Country of ref document: EP

REN Ceased due to non-payment of the annual fee